DK2268299T3 - Sammensætninger til reduktion af ardannelse under sårheling - Google Patents

Sammensætninger til reduktion af ardannelse under sårheling

Info

Publication number
DK2268299T3
DK2268299T3 DK09728723.9T DK09728723T DK2268299T3 DK 2268299 T3 DK2268299 T3 DK 2268299T3 DK 09728723 T DK09728723 T DK 09728723T DK 2268299 T3 DK2268299 T3 DK 2268299T3
Authority
DK
Denmark
Prior art keywords
compositions
wound healing
during wound
reducing scarring
scarring during
Prior art date
Application number
DK09728723.9T
Other languages
English (en)
Inventor
Peter Jozef Jacobus Moonen
Christiaan Peter Maria Reutelingsperger
Ad Vermaire
Original Assignee
Mosamedix Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mosamedix Bv filed Critical Mosamedix Bv
Application granted granted Critical
Publication of DK2268299T3 publication Critical patent/DK2268299T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers with substantial amounts of non-phosphatidyl, i.e. non-acylglycerophosphate, surfactants as bilayer-forming substances, e.g. cationic lipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
DK09728723.9T 2008-04-01 2009-04-01 Sammensætninger til reduktion af ardannelse under sårheling DK2268299T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US4127808P 2008-04-01 2008-04-01
PCT/NL2009/050169 WO2009123454A1 (en) 2008-04-01 2009-04-01 Compositions and method for reducing scar formation in wound healing

Publications (1)

Publication Number Publication Date
DK2268299T3 true DK2268299T3 (da) 2013-10-07

Family

ID=40996620

Family Applications (1)

Application Number Title Priority Date Filing Date
DK09728723.9T DK2268299T3 (da) 2008-04-01 2009-04-01 Sammensætninger til reduktion af ardannelse under sårheling

Country Status (8)

Country Link
US (1) US8377881B2 (da)
EP (1) EP2268299B1 (da)
JP (1) JP5792057B2 (da)
AU (1) AU2009232478B2 (da)
CA (1) CA2720280C (da)
DK (1) DK2268299T3 (da)
ES (1) ES2429122T3 (da)
WO (1) WO2009123454A1 (da)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11246913B2 (en) 2005-02-03 2022-02-15 Intarcia Therapeutics, Inc. Suspension formulation comprising an insulinotropic peptide
EP2359808B1 (en) 2006-08-09 2013-05-22 Intarcia Therapeutics, Inc Osmotic delivery systems and piston assemblies
ES2402172T3 (es) 2007-04-23 2013-04-29 Intarcia Therapeutics, Inc Formulación en suspensión de péptidos insulinotrópicos y usos de los mismos
EP2240155B1 (en) 2008-02-13 2012-06-06 Intarcia Therapeutics, Inc Devices, formulations, and methods for delivery of multiple beneficial agents
US20100178259A1 (en) * 2009-01-12 2010-07-15 The Regents Of The University Of Michigan Reducing fibrosis using matrix metalloproteinase inhibitors
EP3323423B1 (en) 2009-09-28 2020-06-17 Intarcia Therapeutics, Inc Rapid establishment and/or termination of substantial steady-state drug delivery
US20120208755A1 (en) 2011-02-16 2012-08-16 Intarcia Therapeutics, Inc. Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
US9889085B1 (en) 2014-09-30 2018-02-13 Intarcia Therapeutics, Inc. Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
AU2016270984B2 (en) * 2015-06-03 2021-02-25 Intarcia Therapeutics, Inc. Implant placement and removal systems
KR20240037175A (ko) 2016-05-16 2024-03-21 인타르시아 세라퓨틱스 인코포레이티드 글루카곤-수용체 선택적 폴리펩티드 및 이들의 이용 방법
USD840030S1 (en) 2016-06-02 2019-02-05 Intarcia Therapeutics, Inc. Implant placement guide
USD860451S1 (en) 2016-06-02 2019-09-17 Intarcia Therapeutics, Inc. Implant removal tool
IL307966A (en) 2017-01-03 2023-12-01 Intarcia Therapeutics Inc Methods involving continuous administration of a GLP-1 receptor agonist and co-administration of a drug
USD933219S1 (en) 2018-07-13 2021-10-12 Intarcia Therapeutics, Inc. Implant removal tool and assembly

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5360789A (en) 1990-11-20 1994-11-01 Kowa Co., Ltd. Therapeutic agent for skin or corneal disease
US6333347B1 (en) 1999-01-29 2001-12-25 Angiotech Pharmaceuticals & Advanced Research Tech Intrapericardial delivery of anti-microtubule agents
US7511016B2 (en) * 2004-07-07 2009-03-31 Mosamedix B.V. Annexins, derivatives thereof, and annexin-cys variants, as well as therapeutic and diagnostic uses thereof
AU2006325586B2 (en) 2005-12-12 2013-01-31 Mosamedix B.V. Annexin derivatives suitable for pretargeting in therapy and diagnosis

Also Published As

Publication number Publication date
AU2009232478B2 (en) 2014-11-06
WO2009123454A1 (en) 2009-10-08
JP2011516469A (ja) 2011-05-26
EP2268299A1 (en) 2011-01-05
US20110091527A1 (en) 2011-04-21
CA2720280A1 (en) 2009-10-08
US8377881B2 (en) 2013-02-19
CA2720280C (en) 2018-02-20
JP5792057B2 (ja) 2015-10-07
EP2268299B1 (en) 2013-07-17
AU2009232478A1 (en) 2009-10-08
ES2429122T3 (es) 2013-11-13

Similar Documents

Publication Publication Date Title
DK2268299T3 (da) Sammensætninger til reduktion af ardannelse under sårheling
CY2020023I1 (el) Αναστολεiς βητα-λακταμασων
LTPA2019009I1 (lt) C7-fluoru pakeisti tetraciklino junginiai
DK2498829T3 (da) Komponent til sårforbinding
DK2379033T3 (da) Sårplaster
EP2262474A4 (en) METHOD AND COMPOSITIONS FOR WOUND HEALING
DK2634231T3 (da) Sammensætninger
BRPI0906749A2 (pt) Composição
BRPI0913808A2 (pt) composição
BRPI0915593A2 (pt) Curativo de ferida
DE602008002756D1 (de) Bauzusammensetzung
FR2941462B1 (fr) Composition decapante
BRPI0912281A2 (pt) curativo de feridas
BRPI0918602A2 (pt) composto (i)
DK2310034T3 (da) Peptider til behandling af beta-amyloidose
BRPI0917231A2 (pt) composição
IT1392101B1 (it) Composizione comprendente isoflavoni
BRPI0918564A2 (pt) inibidores
IL219439A0 (en) Composition for promoting wound healing
BRPI0910691A2 (pt) compostos e composições como inibidores de itpkb
BRPI0923253A2 (pt) composições depilatória
BRPI0915106A2 (pt) benzimidazóis substituídos para neurofibromatose
DE102009031940B8 (de) Sägeeinrichtung
DK3081097T3 (da) Sammensætning til behandling af infertilitet
DK2257179T3 (da) Sammensætning til konservering af væv